Embecta (EMBC) Other Non-Current Assets (2021 - 2022)

Embecta (EMBC) reported Other Non-Current Assets of $68.5 million for Q2 2022, up 312.65% sequentially from $16.6 million in Q1 2022.

Embecta (EMBC) Other Non-Current Assets (2021 - 2022) Analysis & Trends

Embecta (EMBC) has 2 years of Other Non-Current Assets data on file, last reported at $68.5 million in Q2 2022.

For the quarter ending Q2 2022, Other Non-Current Assets changed N/A year-over-year to $68.5 million; the trailing twelve-month figure through Jun 2022 stood at $68.5 million (changed N/A YoY), and the FY2021 full-year result was $11.3 million, changed N/A from the prior year.
Other Non-Current Assets grew to $68.5 million in Q2 2022, from $16.6 million in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $68.5 million in Q2 2022 to a low of $11.2 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Intuitive Surgical	126.32 Bn	121.10 Bn	1.96 Bn	-
2	Becton Dickinson	44.69 Bn	43.88 Bn	2.15 Bn	-
3	Alcon	32.80 Bn	31.14 Bn	1.53 Bn	376.00 Mn
4	Medline	32.72 Bn	30.49 Bn	1.84 Bn	23.08 Bn
5	Resmed	29.54 Bn	27.88 Bn	890.98 Mn	210.73 Mn
6	West Pharmaceutical Services	23.56 Bn	23.13 Bn	329.20 Mn	82.80 Mn
7	Solventum	14.00 Bn	13.44 Bn	1.10 Bn	848.00 Mn
8	Cooper Companies	13.75 Bn	13.61 Bn	735.40 Mn	672.80 Mn
9	Align Technology	12.03 Bn	10.97 Bn	736.59 Mn	39.83 Mn
10	Embecta	204.88 Mn	11.48 Mn	127.80 Mn	-

Download Data